Botox, Dysport, and Xeomin are three popular brands of botulinum toxin type A that are used to treat facial wrinkles and fine lines. These three injectable treatments are similar in many ways, but there are also some differences between them that patients should be aware of before making a decision about which one to use. In this blog post, we’ll explore the similarities and differences between these three types of botulinum toxin.
Botox is the most well-known brand of botulinum toxin type A. It has been used for decades to treat facial wrinkles and fine lines. Botox is made by Allergan, and it is the most widely studied and tested brand of botulinum toxin. It is also FDA approved for a variety of medical conditions, including migraines and excessive sweating.
Botox works by blocking the signals from the nerves to the muscles. When the muscles can’t contract, they relax, and the wrinkles and fine lines on the face become less noticeable. The effects of Botox usually last around three to six months, depending on the individual patient.
Dysport is another brand of botulinum toxin type A that is used to treat facial wrinkles and fine lines. It is made by Galderma and was FDA approved in 2009. Dysport is similar to Botox in many ways, but it is formulated differently and has a slightly different molecular structure.
Dysport is said to work more quickly than Botox and spread more easily, which means that it may be more effective for treating larger areas of the face. The effects of Dysport usually last around three to six months, depending on the individual patient.
Xeomin is the newest brand of botulinum toxin type A on the market. It is made by Merz Pharmaceuticals and was FDA approved in 2011. Xeomin is similar to Botox and Dysport in many ways, but it is formulated differently and is said to be “naked” because it does not contain any additives or preservatives.
Xeomin is said to be less likely to cause an allergic reaction than Botox or Dysport because it contains only the active ingredient, botulinum toxin type A. The effects of Xeomin usually last around three to six months, depending on the individual patient.